Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
about
Molecular confocal laser endomicroscopy: a novel technique for in vivo cellular characterization of gastrointestinal lesionsControlled drug delivery systems: past forward and future back.Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.In-vivo microscopy in the diagnosis of intestinal neoplasia and inflammatory conditions.Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticlesColon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.Diverse Applications of Nanomedicine.Molecular imaging in gastroenterology.Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease.Nanotechnology in the treatment of inflammatory bowel diseases.Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices.Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.Nanomedicines in gastroenterology and hepatology.Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in miceTiO2-containing and ZnO-containing borosilicate glass-a novel thin glass with exceptional antibiofilm performances to prevent microfouling.Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox.Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study.Development of an advanced diagnostic concept for intestinal inflammation: molecular visualisation of nitric oxide in macrophages by functional poly(lactic-co-glycolic acid) microspheres.Presence of microplastics and nanoplastics in food, with particular focus on seafoodIntestinal organoids containing poly(lactic-co-glycolic acid) nanoparticles for the treatment of inflammatory bowel diseases.Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis
P2860
Q33801366-1F0D0F77-4A6E-485F-BC50-6FB214637F6BQ34079613-BB3EA0C8-187D-4518-B512-E177D024B5A5Q34749181-2F8D28D9-DDB5-4A2A-957D-6A259B957DCFQ35552791-FAC1DC7E-7050-4F18-885C-46B0F36A9855Q35871764-FB431F24-5C96-466F-AE82-E41BEBC79C0CQ35892481-802D7CD5-0F9D-44DE-9BD4-D8E117DD1B66Q37728142-733C0A29-C268-4ABE-B350-EA359DF0EB15Q38121747-2413EE8A-860B-4DDD-8962-A66F14E68359Q38166709-D75B2A6A-2218-4892-A2CA-983E51CB50E4Q38200842-A70F8E55-EC8C-4933-AED5-30DFD5CDDE7EQ38239571-F2B06824-ABBA-49D4-B15D-E0824D19AC63Q38291341-9A7F5C36-298B-43CD-925A-DFD749BD5088Q38370747-CA0BAAEC-9260-4A56-95A4-FEC7F44FB772Q38602136-0D31E3D4-6B16-402A-9E83-8B4315B41379Q38659150-DD62263E-F082-46BD-A3B2-45DEA42518DFQ38718705-11E994CC-743C-44B1-BBB2-2573E477211EQ38740318-69A89286-C006-4A5C-98CC-A052EE10CF33Q38848809-D0240E27-1B9A-4069-BB7F-CBAF3E1B4613Q41348971-21BAB427-C9FB-4CB8-AD83-1AB46E1F06D1Q41469104-D04BE1E4-4779-4701-9F5B-D6CE6FE3E4E2Q47157833-A3B675E9-99A4-4530-A1DA-381CBD3E0899Q47262860-29895342-8CB4-4C7C-847B-62D03CED13DEQ50268454-7D7A2B1B-599A-4222-A6F0-B9B6B97430D3Q50427013-BFBA6DA0-A217-4BA7-81F2-21EF31128C56Q57490343-486C9725-DF8C-46FE-BDC4-DC5A36084F37
P2860
Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Nano- and microscaled particle ...... vivo study in human patients.
@ast
Nano- and microscaled particle ...... vivo study in human patients.
@en
Nano- and microscaled particle ...... vivo study in human patients.
@nl
type
label
Nano- and microscaled particle ...... vivo study in human patients.
@ast
Nano- and microscaled particle ...... vivo study in human patients.
@en
Nano- and microscaled particle ...... vivo study in human patients.
@nl
prefLabel
Nano- and microscaled particle ...... vivo study in human patients.
@ast
Nano- and microscaled particle ...... vivo study in human patients.
@en
Nano- and microscaled particle ...... vivo study in human patients.
@nl
P2093
P1476
Nano- and microscaled particle ...... vivo study in human patients.
@en
P2093
Andreas Stallmach
Carsten Schmidt
Christian Bojarski
Christian Lautenschlaeger
Jörg-Dieter Schulzke
Michael Schumann
P304
P356
10.1016/J.JCONREL.2012.10.019
P407
P577
2012-11-02T00:00:00Z